MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 187 filers reported holding MYRIAD GENETICS INC in Q1 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $96,180,010 | -27.8% | 5,996,260 | +4.4% | 0.02% | -24.0% |
Q2 2023 | $133,165,252 | -14.8% | 5,744,834 | -14.6% | 0.02% | -19.4% |
Q1 2023 | $156,357,390 | +58.8% | 6,730,839 | -0.8% | 0.03% | +55.0% |
Q4 2022 | $98,482,606 | -13.4% | 6,787,223 | +13.8% | 0.02% | -16.7% |
Q3 2022 | $113,778,000 | +14.2% | 5,963,222 | +8.8% | 0.02% | +20.0% |
Q2 2022 | $99,617,000 | -22.4% | 5,482,526 | +7.6% | 0.02% | -9.1% |
Q1 2022 | $128,425,000 | +7.6% | 5,096,235 | +17.8% | 0.02% | +15.8% |
Q4 2021 | $119,391,000 | +14.4% | 4,325,775 | +33.9% | 0.02% | +5.6% |
Q3 2021 | $104,336,000 | +243.6% | 3,231,212 | +225.4% | 0.02% | +260.0% |
Q2 2021 | $30,369,000 | +13.5% | 993,136 | +13.0% | 0.01% | 0.0% |
Q1 2021 | $26,763,000 | +5794.9% | 878,934 | +5179.5% | 0.01% | – |
Q4 2019 | $454,000 | -41.4% | 16,648 | -38.5% | 0.00% | – |
Q3 2019 | $775,000 | -73.4% | 27,072 | -74.2% | 0.00% | -100.0% |
Q2 2019 | $2,911,000 | -5.2% | 104,786 | +13.3% | 0.00% | 0.0% |
Q1 2019 | $3,071,000 | +67.4% | 92,484 | +46.5% | 0.00% | – |
Q4 2018 | $1,835,000 | +84.1% | 63,148 | +191.5% | 0.00% | – |
Q3 2018 | $997,000 | +31.7% | 21,665 | +7.0% | 0.00% | – |
Q2 2018 | $757,000 | +138.1% | 20,252 | +88.4% | 0.00% | – |
Q1 2018 | $318,000 | -46.7% | 10,747 | -70.0% | 0.00% | – |
Q4 2016 | $597,000 | -71.2% | 35,793 | -64.5% | 0.00% | -100.0% |
Q3 2016 | $2,076,000 | -62.2% | 100,893 | -43.8% | 0.00% | 0.0% |
Q2 2016 | $5,498,000 | -16.6% | 179,673 | +2.0% | 0.00% | -50.0% |
Q1 2016 | $6,590,000 | +17.7% | 176,073 | +35.7% | 0.00% | +100.0% |
Q4 2015 | $5,600,000 | +1233.3% | 129,757 | +1058.5% | 0.00% | – |
Q3 2015 | $420,000 | -48.3% | 11,200 | -46.8% | 0.00% | – |
Q3 2014 | $812,000 | 0.0% | 21,045 | +0.8% | 0.00% | – |
Q2 2014 | $812,000 | -84.0% | 20,871 | -85.9% | 0.00% | -100.0% |
Q1 2014 | $5,065,000 | -8.5% | 148,131 | -43.9% | 0.00% | -50.0% |
Q4 2013 | $5,536,000 | -11.6% | 263,837 | -1.0% | 0.00% | 0.0% |
Q3 2013 | $6,261,000 | -15.2% | 266,437 | -3.0% | 0.00% | 0.0% |
Q2 2013 | $7,379,000 | – | 274,650 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
RK Capital | 384,900 | $16,612,000 | 2.90% |
Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |